top of page

Advancing EBV Research: Harnessing LEXSY technology for BGLF4 protein kinase expression and discovery

LEXSY technology offers an efficient and scalable platform for expressing viral replication proteins, facilitating advanced research and vaccine development. 




 
 
 

Commenti


logo Elettrofor

CONTATTACI

0425 474533

comm@elettrofor.it

Via della Cooperazione, 38-40
45100 Borsea (Ro) Italy

© 2026 ELETTROFOR SAS | P.IVA 00950300293 | n. REA 105271

bottom of page